文献速递外周动脉疾病

完成造影对慢性肢体威胁性缺血行腹股沟下下肢旁路术结局的影响

The Impact of Completion Angiography on Outcomes of Infrainguinal Lower Extremity Bypass for Chronic Limb-Threatening Ischemia.
PubMed 文献 · Ann Vasc Surg · 2025-03-05

基于血管质量倡议数据库2011至2023年35525条因慢性肢体威胁性缺血行下肢旁路术的肢体数据,比较术中完成造影与否的围术期及6个月结局。校正混杂因素后,完成造影与术后主要截肢、30天死亡及其他结局均无显著关联;仅在股-胫旁路亚组中,完成造影与6个月主要截肢/死亡风险降低相关(校正HR=0.87,95%CI:0.76-0.99;P=0.040)。作者认为不推荐常规使用完成造影,应由术者自行决定,并需进一步前瞻性研究验证。

要点

  • 完成造影组与非完成造影组术后主要截肢率分别为1.8%与1.7%,差异无统计学意义(P=0.503)。
  • 校正混杂因素后,完成造影与术后主要截肢、30天死亡及其他术后结局均无显著关联。
  • 股-胫旁路亚组中,完成造影与6个月主要截肢/死亡风险降低相关(校正HR=0.87,95%CI:0.76-0.99;P=0.040)。

核心结论

  • 在因慢性肢体威胁性缺血行下肢旁路术的患者中,完成造影不影响术后及6个月结局。
  • 唯一观察到的有益效应见于股-胫旁路,可能与该旁路的长度有关。
  • 基于本研究,不推荐对腹股沟下旁路术常规使用完成造影,决策应由术者自行决定。
  • 需要进一步前瞻性研究验证本研究结果。

研究设计与样本

  • 查询血管质量倡议数据库中2011至2023年因慢性肢体威胁性缺血行下肢旁路术的全部患者。
  • 按是否行完成造影对旁路术进行分层。
  • 共纳入35525条肢体(28824例患者),其中9888条旁路术(27.8%)行完成造影。
  • 采用逻辑回归和Cox回归进行多因素分析。

主要发现

  • 完成造影组与非完成造影组术后主要截肢率分别为1.8%与1.7%(P=0.503)。
  • 完成造影组与非完成造影组术后心肌梗死率分别为2.8%与3.6%(P<0.001),呼吸系统并发症率分别为2.0%与2.5%(P=0.019),再干预率分别为3.5%与4.4%(P<0.001),MACE率分别为4.4%与5.0%(P=0.010),MALE率分别为4.7%与5.7%(P<0.001),均为完成造影组更高。
  • 校正潜在混杂因素后,完成造影与主要截肢无关联(校正OR=0.95,95%CI:0.74-1.23;P=0.703),与30天死亡及其他术后结局也无关联。
  • 多因素分析中,完成造影与6个月结局无关联。
  • 按旁路水平分层的亚组分析中,股-胫旁路行完成造影与6个月主要截肢/死亡风险降低相关(校正HR=0.87,95%CI:0.76-0.99;P=0.040)。

临床怎么用

  • 作者认为,基于本研究,不推荐对腹股沟下旁路术常规使用完成造影。
  • 作者认为,完成造影的决策应由术者自行决定。
  • 作者认为,需要进一步前瞻性研究验证本研究结果。

局限性

  • 原文结论指出需要进一步前瞻性研究验证本研究结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Intraoperative technical success of lower extremity bypass (LEB) is essential for all vascular surgeons. Completion angiography (CA) allows real-time assessment of the bypass, enabling revision for technical defects if needed. However, no consensus exists on the use of CA at the time of LEB. Therefore, we aimed to investigate the impact of CA on perioperative outcomes of LEB in real-world practice. METHODS: We queried all patients with chronic limb-threatening ischemia (CLTI) who underwent LEB during 2011 to 2023 in the Vascular Quality Initiative database. The bypasses were stratified by the performance of CA. The primary outcome was postoperative major amputation. Secondary outcomes included postoperative complications, postoperative reintervention, 30-day mortality, in-hospital major adverse cardiovascular events (MACEs), in-hospital major adverse limb events (MALEs), and 6-month overall survival, limb salvage, amputation-free survival, freedom from reintervention, freedom from MALE, and MALE-free survival. Logistic and Cox regressions were used for the multivariate analysis. RESULTS: A total of 35,525 limbs (28,824 patients) were included in this study. Of these, CA was performed for 9,888 bypasses (27.8%). The rate of postoperative major amputation in bypasses without and with CA was 1.7% and 1.8%, respectively (P = 0.503). The rates of postoperative myocardial infarction (3.6% vs. 2.8%; P < 0.001), respiratory complications (2.5% vs. 2.0%; P = 0.019), reintervention (4.4% vs. 3.5%; P < 0.001), MACE (5.0% vs. 4.4%; P = 0.010), and MALE (5.7% vs. 4.7%; P < 0.001) were higher in bypasses performed with CA. However, after adjusting for potential confounders, CA was not associated with major amputation (adjusted odds ratio = 0.95, 95% confidence interval [CI]: 0.74-1.23; P = 0.703), 30-day mortality, or other postoperative outcomes. Additionally, CA was not associated with 6-month outcomes in the multivariate analyses. However, in a subanalysis of outcomes stratified by the level of bypass, CA was associated with decreased hazards of major amputation/death at 6-month in femorotibial bypasses (adjusted hazards ratio = 0.87, 95% CI: 0.76-0.99; P = 0.040). CONCLUSION: We found that postoperative and 6-month outcomes are not influenced by the performance of CA in CLTI patients undergoing LEB. The only beneficial effect observed was for femorotibial bypasses, likely due to the length of the bypass. Based on this study, the routine use of CA for infrainguinal bypasses is not recommended, and the decision should be made at the surgeon's discretion. However, further prospective studies are necessary to validate our findings.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Zarrintan S, Moacdieh MP, Malas MB, et al. The Impact of Completion Angiography on Outcomes of Infrainguinal Lower Extremity Bypass for Chronic Limb-Threatening Ischemia. Ann Vasc Surg. 2025. PMID: 40054607. doi:10.1016/j.avsg.2025.01.048

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。